| MeSH term | MeSH ID | Detail |
|---|---|---|
| Brain Infarction | D020520 | 17 associated lipids |
| Hirsutism | D006628 | 3 associated lipids |
| Polycystic Ovary Syndrome | D011085 | 14 associated lipids |
| Hypocalcemia | D006996 | 12 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Nerve Degeneration | D009410 | 53 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Periodontitis | D010518 | 22 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Shalhoub V et al. | Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. | 1999 | J. Cell. Biochem. | pmid:10022507 |
| Hsu H et al. | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10097072 |
| Nagai M and Sato N | Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10208850 |
| Burgess TL et al. | The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | 1999 | J. Cell Biol. | pmid:10225954 |
| Kong YY et al. | Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. | 1999 | Immunol. Cell Biol. | pmid:10234557 |
| Yano K et al. | Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. | 1999 | J. Bone Miner. Res. | pmid:10234572 |
| Zhang XD et al. | Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. | 1999 | Cancer Res. | pmid:10364001 |
| Spelsberg TC et al. | The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. | 1999 | Mol. Endocrinol. | pmid:10379881 |
| Yasuda H et al. | A novel molecular mechanism modulating osteoclast differentiation and function. | 1999 | Bone | pmid:10423033 |